Key result
Initial cTnI elevation predicts higher in-hospital mortality in elderly COVID-19 patients.
Why the study?
Data about the significance of cardiac troponin in elderly subjects with COVID-19 are lacking.
Does elevated cardiac troponin I predict all-cause in-hospital mortality in elderly patients hospitalized for COVID-19?
Cohort
No
Does elevated cardiac troponin I predict all-cause in-hospital mortality in elderly patients hospitalized for COVID-19?
In elderly patients hospitalized for COVID-19, an initial elevation in cardiac troponin is a predictor of in-hospital mortality, though serial testing may not add prognostic value.
May support troponin-based risk stratification in elderly COVID-19 inpatients; hypothesis-generating and requires prospective validation.
No takes yet. Share an insight, caveat, or question.
Marzo et al. (2021) conducted a cohort in COVID-19. Increased cardiac troponin I (cTnI) was evaluated on All-cause in-hospital mortality. An initial increase in cardiac troponin I in elderly COVID-19 patients predicts a higher risk of in-hospital death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: